HQL vs. KTF, MCI, SOR, MYN, PPT, MIY, HRZN, MHN, PMO, and WHF
Should you be buying Abrdn Life Sciences Investors stock or one of its competitors? The main competitors of Abrdn Life Sciences Investors include DWS Municipal Income Trust (KTF), Barings Corporate Investors (MCI), Source Capital (SOR), BlackRock MuniYield New York Quality Fund (MYN), Putnam Premier Income Trust (PPT), BlackRock MuniYield Michigan Quality Fund (MIY), Horizon Technology Finance (HRZN), BlackRock MuniHoldings New York Quality Fund (MHN), Putnam Municipal Opportunities Trust (PMO), and WhiteHorse Finance (WHF). These companies are all part of the "investment offices, not elsewhere classified" industry.
DWS Municipal Income Trust (NYSE:KTF) and Abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, community ranking, risk, media sentiment, valuation, dividends and profitability.
DWS Municipal Income Trust received 17 more outperform votes than Abrdn Life Sciences Investors when rated by MarketBeat users. However, 68.35% of users gave Abrdn Life Sciences Investors an outperform vote while only 65.88% of users gave DWS Municipal Income Trust an outperform vote.
DWS Municipal Income Trust has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500. Comparatively, Abrdn Life Sciences Investors has a beta of 0.73, meaning that its share price is 27% less volatile than the S&P 500.
DWS Municipal Income Trust pays an annual dividend of $0.35 per share and has a dividend yield of 3.7%. Abrdn Life Sciences Investors pays an annual dividend of $1.33 per share and has a dividend yield of 9.7%. DWS Municipal Income Trust has raised its dividend for 1 consecutive years.
57.7% of DWS Municipal Income Trust shares are held by institutional investors. Comparatively, 32.2% of Abrdn Life Sciences Investors shares are held by institutional investors. 1.0% of DWS Municipal Income Trust shares are held by company insiders. Comparatively, 10.1% of Abrdn Life Sciences Investors shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
In the previous week, Abrdn Life Sciences Investors had 7 more articles in the media than DWS Municipal Income Trust. MarketBeat recorded 9 mentions for Abrdn Life Sciences Investors and 2 mentions for DWS Municipal Income Trust. DWS Municipal Income Trust's average media sentiment score of 1.69 beat Abrdn Life Sciences Investors' score of 0.00 indicating that Abrdn Life Sciences Investors is being referred to more favorably in the news media.
Summary
Abrdn Life Sciences Investors beats DWS Municipal Income Trust on 6 of the 10 factors compared between the two stocks.
Get Abrdn Life Sciences Investors News Delivered to You Automatically
Sign up to receive the latest news and ratings for HQL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HQL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Abrdn Life Sciences Investors Competitors List
Related Companies and Tools
